In particular, the AD group should be tested for CSF core proteins (Aβ1-42/Aβ1-40, p-tau/t-tau), functional imaging (FdG- and amyloid-PET), and diagnosed accordingly to specific criteria [21,195]. The gene discussed is MAPT; the disease is Alzheimer disease.